This was due to the fact that sarcomas frequently show activation of PI3K/Akt/mTOR signaling [22], [23] and dual PI3K/mTOR inhibitors sensitize neuroblastoma and glioblastoma cells to DOX-induced apoptosis [24], [25]. The gene discussed is MTOR; the disease is glioblastoma.